Biotech entity
Of the tracked stories, 6 of 7 also mention World Health Organization, the most common co-covered peer. Sentiment skews more negative than the wider beat, at 71% negative against 20% across all 280 Biotech stories in the same window. The clearest coverage concentration is clinical-trial: 5 of 7 stories, with the rest divided among 1 other category.
Last mentioned: Aug 20, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 57 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Of the tracked stories, 6 of 7 also mention World Health Organization, the most common co-covered peer. Sentiment skews more negative than the wider beat, at 71% negative against 20% across all 280 Biotech stories in the same window. The clearest coverage concentration is clinical-trial: 5 of 7 stories, with the rest divided among 1 other category. The 7.3 average consequence score is above the beat benchmark of 6.1 in the same window. Source depth averages 2.9 original sources per story, versus 3.8 across the same-window beat baseline. Across a 66-day span, the pace is roughly 0.7 stories per week. The busiest single day carried 2. We currently track 7 Biotech stories that mention Bundibugyo virus, published between June 15, 2026 and August 19, 2026.
Computed from the 7 stories linked to this entity, with beat comparisons drawn from all 280 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Bundibugyo virus. Shared-story counts are live from our verified record — not editorial picks.
3,000 Cases Milestone
Total cases reach 3,075, with 1,354 deaths, amid healthcare strikes and calls for accelerated countermeasure development.
Elikya Treatment Center strike
About 100 health workers at the Elikya Ebola Treatment Center in Bunia strike over unpaid bonuses, paralyzing patient care.
Government releases updated data
Congo's Ministry of Health confirms 2,973 cases and 1,309 deaths, the fastest-growing outbreak on record.
First Experimental Vaccine Volunteer Dosed
Oxford University reports that the first volunteer group has received its candidate vaccine specifically targeting Bundibugyo.
Strike at Bunia General Hospital
Health workers at the region's largest hospital strike over unpaid salaries, stating they have not been paid since the outbreak started.
2,000 Cases Surpassed
Cumulative confirmed cases exceed 2,000, with rapid spread noted in conflict zones.
US aid worker tests positive
CDC confirms a US citizen aid worker in Congo has Ebola; contact tracing and containment measures initiated.
Record outbreak data confirmed
Africa CDC reports the outbreak as the fastest-growing ever at 1,830 confirmed cases and 648 deaths. U.S. aid worker infection announced by CDC.
Clinical trials for treatments launched
Researchers initiate a highly anticipated clinical study to test experimental therapies against the Bundibugyo virus.
Clinical trials for Ebola treatment begin
Researchers launch a highly anticipated study to test experimental therapies against the Bundibugyo strain.
Kenya court suspends U.S.-backed facility
A Kenyan court order halts construction of a U.S.-planned quarantine facility for Americans exposed abroad, complicating evacuation plans.
Kenya Ebola facility suspended
A Kenyan court orders suspension of construction on a US-backed isolation facility for exposed Americans, pausing Trump administration plans.
First US doctor infected
An American doctor working in Congo tests positive during outbreak's first week and is transferred to Germany for treatment.
Congo declares fresh Ebola outbreak
Authorities announce outbreak of Bundibugyo virus after weeks of undetected transmission, according to WHO.
Ebola outbreak officially declared
Congolese authorities declare a fresh Ebola outbreak after weeks of undetected transmission, as later confirmed by WHO.
First U.S. doctor infected and evacuated
An American doctor working in Congo tests positive for Ebola and is transferred to Germany for treatment during the outbreak’s first week.
The current Ebola outbreak in eastern Congo is caused by Bundibugyo virus, a less common species with no approved treatment or vaccine. With 5,000+ cases and 2,300+ deaths, it reveals a critical gap in filovirus countermeasure development and rapid-response platforms.
Source: abcnews.com · krmg.com
DRC’s 17th Ebola outbreak has exploded to 3,075 cases and 1,354 deaths, with 1,000 new infections in just 10 days. The Bundibugyo strain has no approved vaccine or treatment, igniting a biotech race: Oxford University has dosed its first volunteer with an experimental vaccine, while other candidates are fast-tracked, creating high-stakes opportunities for pharma developers.
Source: english.aawsat.com · manilatimes.net
The Bundibugyo virus outbreak is the fastest-growing on record, with a 44% case fatality rate and no approved vaccine or therapy. Biopharma companies and researchers face a critical test as containment fails and the need for medical countermeasures becomes more urgent.
With no approved vaccine or treatment, the rare Bundibugyo ebolavirus driving the Congo outbreak has infected 1,830 people and killed 648. As two U.S. workers fall ill, recently launched clinical trials represent the only hope for a therapeutic breakthrough.
Source: wtvq.com
The Congo Ebola outbreak driven by the rare Bundibugyo virus has ballooned to 1,830 cases with zero approved vaccines or treatments, forcing an urgent launch of clinical trials. For biotech and pharma, this emergency opens a race to develop broad-spectrum filovirus countermeasures.
With no approved therapies for the Bundibugyo Ebola strain and an outbreak surpassing 500 fatalities, two candidate drugs have begun a clinical trial, and a prophylactic agent trial is imminent. The collaborative effort signals a pivot toward rapid, integrated R&D for neglected filoviruses.
The rare Bundibugyo Ebola virus has infected 782 people and killed 181 in Congo, with a record 72 new cases in one day. No approved vaccine or treatment exists for this strain, creating an urgent gap for biotech and pharma to address with rapid countermeasure development.
Bundibugyo virus is linked from 7 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
